(BHVN) Biohaven Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biohaven Pharmaceutical | (BHVN) share price targets
Complete technical analysis of Biohaven Pharmaceutical (BHVN) by charts plus indicators, forecast predictions and share price targets for Biohaven Pharmaceutical (BHVN)
Biohaven Pharmaceutical trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-26 View latest technical analysis
10 day averaged volume of Biohaven Pharmaceutical is 1862520
| Date | Daily Closing Price | Open | High | Low | Volume |
| 26 Tue Mar 2024 | 56.29 | 58.20 | 59.53 | 56.20 | 0.975 times |
| 25 Mon Mar 2024 | 55.23 | 55.62 | 56.32 | 55.13 | 0.655 times |
| 22 Fri Mar 2024 | 55.85 | 55.63 | 56.43 | 55.25 | 0.543 times |
| 21 Thu Mar 2024 | 55.88 | 60.17 | 60.46 | 55.85 | 0.962 times |
| 20 Wed Mar 2024 | 59.36 | 56.02 | 59.37 | 55.43 | 0.495 times |
| 19 Tue Mar 2024 | 56.95 | 56.01 | 57.83 | 55.45 | 1.315 times |
| 18 Mon Mar 2024 | 56.74 | 58.26 | 58.97 | 56.26 | 1.039 times |
| 15 Fri Mar 2024 | 57.07 | 55.32 | 57.95 | 54.95 | 1.936 times |
| 14 Thu Mar 2024 | 56.42 | 58.98 | 59.15 | 55.44 | 1.102 times |
| 13 Wed Mar 2024 | 59.75 | 58.30 | 60.83 | 58.01 | 1.268 times |
My analysis of stock is bullish for shortterm, and stock might move up till 59.3 or till 63.4. Use a stoploss of 55.88 and if this stock hits its stoploss, then it can fall down till 52.46
Share price targets for Biohaven Pharmaceutical (BHVN)
| Target Type | Value |
| Downside Target | 26.39 |
| Downside Target | 32.08 |
| Downside Target | 33.99 |
| Downside Target | 39.84 |
| Downside Target | 43.05 |
| Downside Target | 44.29 |
| Downside Target | 46.25 |
| Downside Target | 49.65 |
| Downside Target | 50.68 |
| Downside Target | 54.00 |
| Downside Target | 55.13 |
| Upside Target | 59.53 |
| Upside Target | 60.46 |
| Upside Target | 60.83 |
| Upside Target | 62.21 |
Intraday share price targets for Biohaven Pharmaceutical (BHVN)
| Target Type | Value |
| Downside Intraday Target | 54.44 |
| Downside Intraday Target | 52.58 |
| Upside Intraday Target | 58.84 |
| Upside Intraday Target | 61.38 |
| Upside Intraday Target | 56.98 |
Weekly technical analysis of Biohaven Pharmaceutical (BHVN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 26 Tue Mar 2024 | 56.29 | 55.62 | 59.53 | 55.13 | 0.374 times |
| 22 Fri Mar 2024 | 55.85 | 58.26 | 60.46 | 55.25 | 0.751 times |
| 15 Fri Mar 2024 | 57.07 | 57.56 | 60.83 | 54.00 | 1.226 times |
| 08 Fri Mar 2024 | 57.97 | 51.50 | 62.21 | 51.15 | 1.377 times |
| 01 Fri Mar 2024 | 49.54 | 47.20 | 51.78 | 44.39 | 2.032 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biohaven Pharmaceutical (BHVN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 26 Tue Mar 2024 | 56.29 | 47.48 | 62.21 | 46.25 | 1.951 times |
| 29 Thu Feb 2024 | 48.14 | 44.92 | 50.68 | 43.05 | 0.735 times |
| 31 Wed Jan 2024 | 44.48 | 42.09 | 49.65 | 39.84 | 0.832 times |
| 29 Fri Dec 2023 | 42.80 | 33.20 | 44.29 | 32.08 | 1.16 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Biohaven Pharmaceutical (BHVN)
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biohaven Pharmaceutical stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Biohaven Pharmaceutical in short term but the sell signal is initial and weak.
Biohaven Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biohaven Pharmaceutical in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biohaven Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 57.03 and Biohaven Pharmaceutical (BHVN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biohaven Pharmaceutical (BHVN) stock. Volume based technical analysis of Biohaven Pharmaceutical (BHVN) stock is negative.
Biohaven Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biohaven Pharmaceutical stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Biohaven Pharmaceutical in short term but the sell signal is initial and weak.
Biohaven Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biohaven Pharmaceutical in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biohaven Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 57.03 and Biohaven Pharmaceutical (BHVN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biohaven Pharmaceutical (BHVN) stock. Volume based technical analysis of Biohaven Pharmaceutical (BHVN) stock is negative.
Biohaven Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.